Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

ClinicalTrials.gov ID: NCT05147220

Public ClinicalTrials.gov record NCT05147220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

Study identification

NCT ID
NCT05147220
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,000 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 16, 2021 (Actual)
Primary completion
Jul 21, 2026 (Actual)
Completion
Oct 30, 2030 (Estimated)
Last update posted
Aug 18, 2026

2021 – 2030

United States locations

U.S. sites
52
U.S. states
27
U.S. cities
50
Facility City State ZIP Site status
AZ Integrated Neuro and Spine Phoenix Arizona 85037 —
Center for Neurosciences Tucson Arizona 85718 —
The Belinga Clinic Fort Smith Arkansas 72916 —
The Research and Education Inst of Alta Bates Summit Med Grp Berkeley California 94705 —
The Neuron Clinic Chula Vista California 91910 —
Glendale Adventist Medical Center Glendale California 91206 —
Hoag Health System Newport Beach California 92663 —
SC3 Research Pasadena Pasadena California 91105 —
Neuro Center Pomona California 91767 —
Alpine Clinical Research Center Boulder Colorado 80301 —
Christiana Care Health Services Newark Delaware 19713 —
Washington Hospital Center Washington D.C. District of Columbia 20010 —
Neurology of Central FL Res Ctr Altamonte Springs Florida 32714 —
Arrow Clinical Trials Daytona Beach Florida 32117 —
Homestead Assoc In Research Inc Homestead Florida 33033 —
Reliant Medical Research Miami Florida 33165 —
Neurological Services of Orlando PA Orlando Florida 32806 —
Orlando Health Clinical Trials Orlando Florida 32806 —
Comprehensive Neurology Clinic Orlando Florida 32825 —
Neurology Associates of Ormond Beach Ormond Beach Florida 32174 —
Neurostudies Inc Port Charlotte Florida 33952 —
Accel Research Sites St Pete-Largo Seminole Florida 33777 —
University Of South Florida Tampa Florida 33612 —
Conquest Research Winter Park Florida 32789 —
Rush University Medical Center Chicago Illinois 60612 —
IU Health Inc Fort Wayne Indiana 46815 —
College Park Family Care Center Overland Park Kansas 66210 —
Norton Neurology MS Services Louisville Kentucky 40207 —
American Oncology Partners PA Center for Cancer and Blood Disorders Bethesda Maryland 20817 —
Neurology Center of New England PC Foxborough Massachusetts 02035 —
Wayne State University Multiple Sclerosis Clinic Detroit Michigan 48201 —
The MS Center for Innovation in Care St Louis Missouri 63131 —
SCL Health Billings Montana 59101 —
Jersey Shore University Medical Ctr Neptune City New Jersey 07753 —
Neurological Associates of Long Island PC Lake Success New York 11042 —
NYU Langone Med Center CV Research New York New York 10016 —
The Neurological Institute PA Charlotte North Carolina 28204 —
Velocity Clinical Research Raleigh North Carolina 27607 —
Columbus Neuroscience Westerville Ohio 43082 —
Multiple Sclerosis Center of Excellence of OMRF Oklahoma City Oklahoma 73104 —
Providence St Vincent Med Center Portland Oregon 97225 —
University Of Pittsburgh Medical Ctr Magee-Womens Hospital Pittsburgh Pennsylvania 15213 —
Reading Hospital Reading Pennsylvania 19611 —
Palmetto Clinical Research Summerville South Carolina 29485 —
Texas Neurology Dallas Texas 75206 —
John Peter Smith Hospital Fort Worth Texas 76104 —
Neuro Eye Clinical Trials Inc Houston Texas 77074 —
DHR Health Institute McAllen Texas 78504 —
Saturn Research Solutions LLC Plano Texas 75024 —
MS Center of Greater Washington, P.C. Vienna Virginia 22182 —
University of Wisconsin Madison Madison Wisconsin 53792 —
Neuroscience Group Neenah Wisconsin 54956 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 148 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05147220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05147220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →